Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02488759
Title A Study to Investigate the Safety and Efficacy of Nivolumab in Virus-associated Tumors (CheckMate358)
Acronym CheckMate358
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | GBR | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Local Institution - 0033 Tampa Florida 33612-9497 United States Details
Local Institution - 0003 Atlanta Georgia 30322 United States Details
Local Institution - 0023 Lutherville Maryland 21093 United States Details
Local Institution - 0002 Boston Massachusetts 02114 United States Details
Local Institution - 0019 Boston Massachusetts 02114 United States Details
Local Institution - 0020 Boston Massachusetts 02114 United States Details
Local Institution - 0035 Ann Arbor Michigan 48109 United States Details
Local Institution - 0036 New York New York 10065 United States Details
Local Institution - 0022 Charlotte North Carolina 28204 United States Details
Local Institution - 0005 Oklahoma City Oklahoma 73104 United States Details
Local Institution - 0004 Portland Oregon 97213 United States Details
Local Institution - 0029 Pittsburgh Pennsylvania 15232 United States Details
Local Institution - 0001 Sioux Falls South Dakota 57104 United States Details
Local Institution - 0021 Seattle Washington 98109 United States Details
Local Institution - 0012 Brussels 1000 Belgium Details
Local Institution - 0014 Brussels 1090 Belgium Details
Local Institution - 0013 Bruxelles 1200 Belgium Details
Local Institution - 0031 Marseille Cedex 9 13273 France Details
Local Institution - 0038 Paris 75475 France Details
Local Institution - 0032 Toulouse Cedex 9 31059 France Details
Local Institution - 0030 Vlllejuif 94800 France Details
Local Institution - 0027 Essen 45147 Germany Details
Local Institution - 0028 Heilbronn 74078 Germany Details
Local Institution - 0039 Kashiwa-shi Chiba 2778577 Japan Details
Local Institution - 0040 Chuo-ku Tokyo 1040045 Japan Details
Local Institution - 0041 Koto-ku Tokyo 135-8550 Japan Details
Local Institution - 0024 Seoul 03080 Korea, Republic of Details
Local Institution - 0056 Mexico City Distrito Federal 04700 Mexico Details
Local Institution Oaxaca de Juarez Oaxaca 68040 Mexico Details
Local Institution - 0046 Merida Yucatan 97138 Mexico Details
Local Institution - 0011 Amsterdam 1066 CX Netherlands Details
Local Institution - 0034 Utrecht 3584CX Netherlands Details
Local Institution - 0018 Barcelona 08035 Spain Details
Local Institution - 0017 Madrid 28050 Spain Details
Local Institution - 0016 Navarra 31008 Spain Details
Local Institution - 0037 Tainan 70403 Taiwan Details
Local Institution - 0026 Taipei 10002 Taiwan Details
Local Institution - 0006 Glasgow Lanarkshire G12 OYN United Kingdom Details
Local Institution - 0010 Birmingham West Midlands B15 2TH United Kingdom Details
Local Institution - 0008 London W1T 7HA United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field